Article ID Journal Published Year Pages File Type
323920 Hormones and Behavior 2006 8 Pages PDF
Abstract

Increasing cAMP, or activating dopamine type 1 (D1) or GABAA/benzodiazepine receptor complexes (GBRs), in the ventral tegmental area (VTA) enhances lordosis of rodents. Whether D1- and/or GBR-mediated increases in progestin-facilitated lordosis involve the cAMP-synthesizing enzyme, adenylyl cyclase, in the VTA, was investigated. In Experiment 1, ovariectomized estradiol (E2; 10 μg at h 0) + progesterone (P; 250 μg at h 45)-primed hamsters first received bilateral infusions of the adenylyl cyclase inhibitor, 2′,5′-dideoxyadenosine (DDA; 12 μM/side), or vehicle, and then were infused with the D1 agonist, SKF38393 (100 ng/side), the GBR agonist, muscimol (100 ng/side), or vehicle, to the VTA. Lordosis was evaluated before and 30 min after each infusion. In Experiment 2, ovariectomized, E2-primed (10 μg at h 0) rats received VTA infusions of DDA (12 μM/side) or vehicle; SKF38393 (100 ng/side), muscimol (100 ng/side), or vehicle; and the neurosteroid, 5α-pregnan-3α-ol-20-one (3α,5α-THP; 100 or 200 ng/side), or β-cyclodextrin vehicle. Lordosis was assessed before the series of infusions, immediately after drug infusions and 10 or 60 min after 3α,5α-THP infusions. Progestin- or progestin plus SKF38393-or muscimol-mediated increases in lordosis were blocked by DDA pretreatment. Thus, in the VTA, progestins' membrane action may involve adenylyl cyclase.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology
Authors
, , ,